F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES
F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES is named as the registrant in 1 lobbying report we hold for 2026-Q2, for 1 client. 0 reports of 1 compared with the due date were posted after it.
Clients and amounts
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
| Client | Amount the report states, by quarter | Reports |
|---|---|---|
| F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATESThe registrant lobbying for itself | 2026-Q2: $90,000 in its own lobbying expenses | 1 |
Lobbyists named in these reports
- BRENNA MARIE LEAMER · 1 report
- CASSANDRA RICCI · 1 report
- NANCY CARLTON · 1 report
- RUSSELL CONWELL RING · 1 report
Bills named, and how the House and the Senate voted
6 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 1108Diagnostics Testing Preparedness Plan Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 5269RESULTS Act | Introduced | No recorded vote in our record |
| H.R. 5300Department of State Policy Provisions Act | Introduced | No recorded vote in our record |
| H.R. 5343Ensuring Patient Access to Critical Breakthrough Products Act | Introduced | No recorded vote in our record |
| S. 1717Ensuring Patient Access to Critical Breakthrough Products Act of 2025 | Introduced | No recorded vote in our record |
| S. 2761RESULTS Act | Introduced | No recorded vote in our record |
Issues named: Foreign Relations (1), Health Issues (1), Medical/Disease Research/Clinical Labs (1), Medicare/Medicaid (1).
Every report
| Client | Kind, as filed | Posted | Report |
|---|---|---|---|
| F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATESMedicare/Medicaid, Foreign Relations, Health Issues, Medical/Disease Research/Clinical Labs | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this registrant reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
| Member | Paid to, as reported | Amount | Date | Report |
|---|---|---|---|---|
| Brian K. Fitzpatrick RRepublican | BRIAN FITZPATRICK FOR ALL OF USFrom ROCHE DIAGNOSTICS CORPORATION PAC (ROCHE DXPAC) | $1,000 | The report on LDA.gov | |
| Brian K. Fitzpatrick RRepublican | BRIAN FITZPATRICK FOR ALL OF USFrom ROCHE DIAGNOSTICS CORPORATION PAC (ROCHE DXPAC) | $2,000 | The report on LDA.gov | |
| Brian K. Fitzpatrick RRepublican | BRIAN FITZPATRICK FOR ALL OF USFrom ROCHE DIAGNOSTICS CORPORATION PAC (ROCHE DXPAC) | $1,000 | The report on LDA.gov |
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.